5 & 6 June 2024
Palexpo, Geneva
Menu Close

Merck Boosts Commercial Capacity in France as Part of New Millipore® CTDMO Services

Merck, a leading science and technology company, has opened a commercial facility for its new Millipore® CTDMO Services offering at the company’s site in Martillac, France. The 2,700-square-meter facility will provide global supply of commercial drug substances, including mAbs and other recombinant proteins, from an integrated site featuring state-of-the-art single-use equipment and onsite regulatory, quality and technical experts.

“Our clients are pioneering modern medicine and managing multiple partners, supply chain needs and complex priorities and are turning to Merck to help them navigate the complexity and provide flexibility and scale,” said Dirk Lange, Head of Life Science Services, Life Science business sector of Merck. “With this facility and our global Millipore® CTDMO Services network, we offer truly differentiated services, including templates for drug development, manufacturing and commercialization to accelerate molecules to market with one experienced partner.”

Follow us:

Share this article: